| Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors S Sofi, U Mehraj, H Qayoom, S Aisha, A Almilaibary, M Alkhanani, MA Mir Medical Oncology 39 (9), 133, 2022 | 88 | 2022 |
| Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications S Sofi, U Mehraj, H Qayoom, S Aisha, SMB Asdaq, A Almilaibary, MA Mir Medical oncology 39 (6), 106, 2022 | 76 | 2022 |
| Expression pattern and prognostic significance of baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5) in breast cancer: a comprehensive analysis U Mehraj, S Aisha, S Sofi, MA Mir Advances in Cancer Biology-Metastasis 4, 100037, 2022 | 48 | 2022 |
| Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis H Qayoom, S Sofi, MA Mir Immunologic research 71 (4), 588-599, 2023 | 45 | 2023 |
| A comprehensive analysis of notch signaling genes in breast cancer: expression pattern and prognostic significance S Sofi, H Qayoom, N Jan, N Khaliq, A Almilaibary, MA Mir Advances in cancer biology-metastasis 7, 100104, 2023 | 37 | 2023 |
| Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation. S Sofi, N Jan, H Qayoom, M Alkhanani, A Almilaibary Saudi Journal of Biological Sciences 30 (9), 103774-103774, 2023 | 33 | 2023 |
| Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study H Qayoom, U Mehraj, S Sofi, S Aisha, A Almilaibary, M Alkhanani, MA Mir Medical oncology 39 (10), 158, 2022 | 33 | 2022 |
| Identification and analysis of dysregulated fatty acid metabolism genes in breast cancer subtypes U Yousuf, S Sofi, A Makhdoomi, MA Mir Medical Oncology 39 (12), 256, 2022 | 31 | 2022 |
| Cryptolepine Targets TOP2A and Inhibits Tumor Cell Proliferation in Breast Cancer Cells - An In vitro and In silico Study U Mehraj, H Qayoom, S Shafi, P Farhana, SMB Asdaq, MA Mir Anti-Cancer Agents in Medicinal Chemistry-Anti-Cancer Agents) 22 (17), 3025-3037, 2022 | 31 | 2022 |
| Proteomics: a groundbreaking development in cancer biology MA Mir, H Qayoom, S Sofi, N Jan Proteomics, 31-53, 2023 | 29 | 2023 |
| Expression pattern and prognostic significance of CDKs in breast cancer: an integrated bioinformatic study U Mehraj, S Sofi, B Alshehri, MA Mir Cancer Biomarkers 34 (3), 505-519, 2022 | 29 | 2022 |
| Targeting breast cancer stem cells through retinoids: a new hope for treatment N Jan, S Sofi, H Qayoom, BU Haq, A Shabir, MA Mir Critical Reviews in Oncology/Hematology, 104156, 2023 | 28 | 2023 |
| Proteomics: application of next-generation proteomics in cancer research MA Mir, H Qayoom, S Sofi, N Jan Proteomics, 55-76, 2023 | 28 | 2023 |
| Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis BU Haq, H Qayoom, S Sofi, N Jan, A Shabir, I Ahmad, F Ahmad, ... Frontiers in Pharmacology 14, 1333447, 2024 | 23 | 2024 |
| Exploring the role of trifarotene against RAR-α: an investigation of expression pattern and clinicopathological significance of RAR-α in breast cancer N Jan, S Sofi, A Abo Mansoor, A Abdelrahim, I Ahmad, A Almilabairy, ... Frontiers in Pharmacology 15, 1361679, 2024 | 19 | 2024 |
| Clinicopathological and Prognostic Significance of Bcl2 in Breast Cancer: A Comprehensive In Silico and In Vitro Study S Sofi, U Mehraj, N Jan, SF Ahmad, MA Mir Preprints, 2023 | 19 | 2023 |
| Introduction to Metronomic Chemotherapy MA Mir, N Jan, S Sofi Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment, 1-14, 2024 | 18 | 2024 |
| Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology N Jan, S Sofi, H Qayoom, A Shabir, BU Haq, MA Macha, A Almilaibary, ... Heliyon 10 (3), 2024 | 15 | 2024 |
| Integrating immunotherapy with chemotherapy: a new approach to drug repurposing H Qayoom, U Mehraj, S Aisha, S Sofi, MA Mir Drug repurposing molecular aspects and therapeutic applications, 2021 | 12 | 2021 |
| Chlorogenic acid restores ovarian functions in mice with letrozole-induced polycystic ovarian syndrome via modulation of adiponectin receptor MZH Shah, VK Shrivastava, S Sofi, YF Jamous, MF Khan, FK Alkholifi, ... Biomedicines 11 (3), 900, 2023 | 11 | 2023 |